Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancerYoung‐Won Cho, Tae‐You Kim|Molecular Oncology|2021Cited by 43
<scp>FGFR</scp>2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers <i>in vitro</i>Yongjun Cha, Tae‐You Kim|Molecular Oncology|2018Cited by 33
Identifying TP53RK as a key regulator of colorectal cancer survival and a potential therapeutic targetYoung Hee Choi, Tae‐You Kim|Scientific Reports|2025Cited by 1